Cheryl Maley
Chief Executive Officer
Starpharma
Cheryl Maley is Chief Executive Officer of Starpharma, an Australian biotechnology company advancing dendrimer based therapies for patients with unmet needs, including cancer. With 25+ years in pharma and 20 in leadership across Novartis and AbbVie, she has led innovation, commercial strategy, and growth in Australia, Asia, and global markets.
At Novartis, Cheryl served as Country Head and President of Novartis Philippines and as General Manager, Oncology for Australia and New Zealand, where she oversaw the launch of multiple products in oncology, neurology, cardiovascular and immunology.
A champion of equity in STEMM, she builds diverse teams, embeds inclusion into strategy, and expands sponsorship and visibility pathways for women. Cheryl is committed to investing in skills, mentoring, and early career opportunities to transform leadership and talent pathways across the STEMM ecosystem.
SESSIONS
Day 1
9:40
C-Suite leadership panel: Transforming pathways for equity in STEMM
Building and retaining diverse talent across the STEMM ecosystem
Reframing equity and inclusion as critical to workforce and leadership strategies
Creating visibility and sponsorship pathways for women in STEMM
Investing in skills, mentoring, and early-career opportunities
Cheryl Maley, Chief Executive Officer, Starpharma
Brooke Mills, Co-founder & Chief Executive Officer, Astraea Technologies
Katherine Boiciuc, Chief Technology Officer Oceania, EY
Associate Professor Michael Ben-Meir, Chief Executive Officer, Royal Flying Doctor Service Victoria